Cover Image
Market Research Report

Preclinical Imaging (In-VIVO)

Published by Global Industry Analysts, Inc. Product code 908755
Published Content info 88 Pages
Delivery time: 1-2 business days
Price
Back to Top
Preclinical Imaging (In-VIVO)
Published: October 1, 2019 Content info: 88 Pages
Description

Preclinical Imaging (In-VIVO) market worldwide is projected to grow by US$361.3 Million, driven by a compounded growth of 5.9%. Preclinical imaging modalities, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$686 Million by the year 2025, Preclinical imaging modalities will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$16.7 Million to the region's size and clout in the next 5 to 6 years. Over US$16.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Preclinical imaging modalities will reach a market size of US$53.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.7% over the next couple of years and add approximately US$62.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Aspect Imaging; Bruker Corporation; FUJIFILM Holdings Corporation; LI-COR, Inc. (LI-COR Biosciences); Mediso Ltd. ; MILabs BV; Miltenyi Biotec GmbH; MR Solutions Ltd.; PerkinElmer, Inc.; Trifoil Imaging, Inc.

Table of Contents
Product Code: MCP14177

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Preclinical Imaging (In-VIVO) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Preclinical Imaging (In-VIVO) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Preclinical Imaging (In-VIVO) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Preclinical Imaging (In-VIVO) Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Preclinical imaging modalities (Segment) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 5: Preclinical imaging modalities (Segment) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 6: Preclinical imaging modalities (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Preclinical imaging reagents (Segment) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: Preclinical imaging reagents (Segment) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 9: Preclinical imaging reagents (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Preclinical Imaging (In-VIVO) Market Share (in %) by Company: 2019 & 2025
    • TABLE 10: United States Preclinical Imaging (In-VIVO) Market Estimates and Projections in US$ Thousand by Segment: 2018 to 2025
    • TABLE 11: Preclinical Imaging (In-VIVO) Market in the United States by Segment: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 12: United States Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 13: Canadian Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018 to 2025
    • TABLE 14: Canadian Preclinical Imaging (In-VIVO) Historic Market Review by Segment in US$ Thousand: 2009-2017
    • TABLE 15: Preclinical Imaging (In-VIVO) Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025
  • JAPAN
    • TABLE 16: Japanese Market for Preclinical Imaging (In-VIVO): Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 17: Preclinical Imaging (In-VIVO) Market in Japan: Historic Sales Analysis in US$ Thousand by Segment for the Period 2009-2017
    • TABLE 18: Japanese Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 19: Chinese Preclinical Imaging (In-VIVO) Market Growth Prospects in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 20: Preclinical Imaging (In-VIVO) Historic Market Analysis in China in US$ Thousand by Segment: 2009-2017
    • TABLE 21: Chinese Preclinical Imaging (In-VIVO) Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Preclinical Imaging (In-VIVO) Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 22: European Preclinical Imaging (In-VIVO) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 23: Preclinical Imaging (In-VIVO) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 24: European Preclinical Imaging (In-VIVO) Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: European Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018-2025
    • TABLE 26: Preclinical Imaging (In-VIVO) Market in Europe in US$ Thousand by Segment: A Historic Review for the Period 2009-2017
    • TABLE 27: European Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 28: Preclinical Imaging (In-VIVO) Market in France by Segment: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 29: French Preclinical Imaging (In-VIVO) Historic Market Scenario in US$ Thousand by Segment: 2009-2017
    • TABLE 30: French Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 31: Preclinical Imaging (In-VIVO) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 32: German Preclinical Imaging (In-VIVO) Historic Market Analysis in US$ Thousand by Segment: 2009-2017
    • TABLE 33: German Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 34: Italian Preclinical Imaging (In-VIVO) Market Growth Prospects in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 35: Preclinical Imaging (In-VIVO) Historic Market Analysis in Italy in US$ Thousand by Segment: 2009-2017
    • TABLE 36: Italian Preclinical Imaging (In-VIVO) Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Preclinical Imaging (In-VIVO): Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2018-2025
    • TABLE 38: Preclinical Imaging (In-VIVO) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Segment for the Period 2009-2017
    • TABLE 39: United Kingdom Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018-2025
    • TABLE 41: Preclinical Imaging (In-VIVO) Market in Rest of Europe in US$ Thousand by Segment: A Historic Review for the Period 2009-2017
    • TABLE 42: Rest of Europe Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 43: Preclinical Imaging (In-VIVO) Market in Asia-Pacific by Segment: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 44: Asia-Pacific Preclinical Imaging (In-VIVO) Historic Market Scenario in US$ Thousand by Segment: 2009-2017
    • TABLE 45: Asia-Pacific Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 46: Rest of World Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018 to 2025
    • TABLE 47: Rest of World Preclinical Imaging (In-VIVO) Historic Market Review by Segment in US$ Thousand: 2009-2017
    • TABLE 48: Preclinical Imaging (In-VIVO) Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

IV. COMPETITION

  • ASPECT IMAGING
  • BRUKER CORPORATION
  • FUJIFILM HOLDINGS CORPORATION
  • LI-COR, INC. (LI-COR BIOSCIENCES)
  • MILABS BV
  • MR SOLUTIONS
  • MEDISO
  • MILTENYI BIOTEC GMBH
  • PERKINELMER
  • TRIFOIL IMAGING

V. CURATED RESEARCH

Back to Top